September 11, 2025 COVID Exits Top 10 as US Deaths Fall Age-adjusted US death rate fell 3.8% in 2024, the lowest since 2020, provisional data show Conexiant
August 15, 2025 Similar Efficacy, Improved Safety Achieved Without Concurrent Cisplatin for Locoregionally Advanced Nasopharyngeal Cancer The ASCO Post
August 15, 2025 Nivolumab Added to Chemoradiotherapy Reduced Recurrence Risk in High-Risk Head and Neck Cancer The ASCO Post
July 29, 2025 Similar Efficacy, Improved Safety Achieved Without Concurrent Cisplatin for Locoregionally Advanced Nasopharyngeal Cancer The ASCO Post
August 22, 2025 Kinase Inhibitor Approved for Nonsquamous NSCLC With HER2 TKD–Activating Mutations The ASCO Post
August 15, 2025 Mount Sinai Neurosurgeon Leads Development of First CNS Guidelines for Treating Functioning Pituitary Adenomas Mount Sinai New York
August 15, 2025 Nivolumab Added to Chemoradiotherapy Reduced Recurrence Risk in High-Risk Head and Neck Cancer The ASCO Post
August 22, 2025 Kinase Inhibitor Approved for Nonsquamous NSCLC With HER2 TKD–Activating Mutations The ASCO Post